NXTC
Price
$8.89
Change
-$0.14 (-1.55%)
Updated
Oct 23 closing price
Capitalization
24.17M
6 days until earnings call
Intraday Buy/Sell Signals
PRAX
Price
$178.01
Change
-$6.42 (-3.48%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
4.59B
13 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

NXTC vs PRAX

Header iconNXTC vs PRAX Comparison
Open Charts NXTC vs PRAXBanner chart's image
NextCure
Price$8.89
Change-$0.14 (-1.55%)
Volume$11.34K
Capitalization24.17M
Praxis Precision Medicines
Price$178.01
Change-$6.42 (-3.48%)
Volume$11.77K
Capitalization4.59B
NXTC vs PRAX Comparison Chart in %
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. PRAX commentary
Oct 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a Hold and PRAX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 24, 2025
Stock price -- (NXTC: $8.89 vs. PRAX: $178.01)
Brand notoriety: NXTC and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 33% vs. PRAX: 76%
Market capitalization -- NXTC: $24.17M vs. PRAX: $4.59B
NXTC [@Biotechnology] is valued at $24.17M. PRAX’s [@Biotechnology] market capitalization is $4.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, NXTC is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 2 TA indicator(s) are bullish while PRAX’s TA Score has 7 bullish TA indicator(s).

  • NXTC’s TA Score: 2 bullish, 4 bearish.
  • PRAX’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than NXTC.

Price Growth

NXTC (@Biotechnology) experienced а +2.18% price change this week, while PRAX (@Biotechnology) price change was +9.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +11.17%, and the average quarterly price growth was +62.10%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

PRAX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($4.59B) has a higher market cap than NXTC($24.2M). PRAX YTD gains are higher at: 131.302 vs. NXTC (-3.913). NXTC has higher annual earnings (EBITDA): -61.2M vs. PRAX (-271.35M). PRAX has more cash in the bank: 301M vs. NXTC (35.3M). PRAX has less debt than NXTC: PRAX (755K) vs NXTC (4.67M). PRAX has higher revenues than NXTC: PRAX (7.77M) vs NXTC (0).
NXTCPRAXNXTC / PRAX
Capitalization24.2M4.59B1%
EBITDA-61.2M-271.35M23%
Gain YTD-3.913131.302-3%
P/E RatioN/AN/A-
Revenue07.77M-
Total Cash35.3M301M12%
Total Debt4.67M755K618%
FUNDAMENTALS RATINGS
NXTC: Fundamental Ratings
NXTC
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NXTCPRAX
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PALI1.770.14
+8.59%
Palisade Bio
LOMA8.060.36
+4.68%
Loma Negra Compania Industrial Argentina Sociedad Anonima
DEO96.87-0.95
-0.97%
Diageo plc
TRSG1.45-0.03
-1.82%
Tungray Technologies
PRAX178.01-6.42
-3.48%
Praxis Precision Medicines

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with BEAM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
-3.48%
BEAM - PRAX
40%
Loosely correlated
+1.88%
ABCL - PRAX
39%
Loosely correlated
+4.39%
BHVN - PRAX
37%
Loosely correlated
-1.09%
RAPP - PRAX
35%
Loosely correlated
-2.20%
VERU - PRAX
35%
Loosely correlated
-9.71%
More